Dow Development Labs LLC

With core expertise in liquid and semi-solid drug products, Dow Development Laboratories develops, manufactures, packages and tests topical semi-solid and liquid oral products for clinical use, designed to be disease-compatible, cosmetically elegant and stable, filled, packaged and labeled in-house for distribution to clinical sites. Its formulation, analytical, production, quality and clinical labeling teams bring decades of experience moving products quickly toward regulatory approval, supported by parent company Symbio, a clinical CRO.